Details for New Drug Application (NDA): 210225
✉ Email this page to a colleague
The generic ingredient in IVERMECTIN is ivermectin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
Summary for 210225
Tradename: | IVERMECTIN |
Applicant: | Padagis Israel |
Ingredient: | ivermectin |
Patents: | 0 |
Suppliers and Packaging for NDA: 210225
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-102 | 45802-102-84 | 1 TUBE in 1 CARTON (45802-102-84) / 45 g in 1 TUBE |
IVERMECTIN | ivermectin | CREAM;TOPICAL | 210225 | ANDA | Bryant Ranch Prepack | 72162-2294 | 72162-2294-2 | 1 TUBE in 1 CARTON (72162-2294-2) / 45 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
Approval Date: | Apr 13, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription